Julian Chandler
Associate Director, Discovery Research Alexion Pharmaceuitcals
Experienced researcher with a demonstrated history of working in the biotechnology industry. Skilled in disease identification and inventor of novel therapeutic intervention. Project leader with management experience. Assay development, model selection, small molecules, antibody discovery and pre-clinical expert. Strong research professional and creative scientist that enjoys working with others to solve challenging problems.
Seminars
Wednesday 22nd July 2026
Panel Discussion: Positioning Novel Mechanisms in the Myasthenia Gravis Market to Deliver Differentiated Patient Benefit
8:30 am
- Comparing how FcRn inhibition, complement blockade, B-cell depletion and CAR-T differ mechanistically and where each may sit best based on disease biology
- Examining how mechanistic sequencing could address patients exposed to prior lines of therapy without clear biomarkerguidance
- Identifying emerging strategies for treating MG patients who fail FcRn inhibition, IgG degraders or complement therapies
- Gain insight into how to position assets in a saturated market while addressing inadequate responders and future curative ambition
